PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients (PAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01373684
Recruitment Status : Recruiting
First Posted : June 15, 2011
Last Update Posted : December 21, 2017
Hoffmann-La Roche
Information provided by (Responsible Party):
Foundation for Liver Research

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2019
  Estimated Study Completion Date : October 2019